RDEA806
- Generic Name
- RDEA806
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Background
RDEA806 is a new HIV non-nucleoside reverse transcriptase inhibitor (NNRTI) with a high genetic barrier to resistance and a broad spectrum of activity.
- Indication
For the treatment of HIV-1 infection in combination with appropriate antiretroviral agents when therapy is warranted.
- Associated Conditions
- -
- Associated Therapies
- -
A Study of RDEA806 in Hyperuricemic Subjects With Symptomatic Gout
- First Posted Date
- 2008-08-26
- Last Posted Date
- 2014-02-06
- Lead Sponsor
- Ardea Biosciences, Inc.
- Target Recruit Count
- 3
- Registration Number
- NCT00741442
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath